Loomis, Sayles & Company’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-113,189	Closed	-$11.9M	–	768
2014 Q2	$11.9M	Buy	113,189 +24,831	+28%	+$2.6M	0.03%	473
2014 Q1	$7.33M	Buy	+88,358	New	+$7.33M	0.02%	519